Breaking News
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
February 21, 2019 - A skeptical look at popular diets: Going gluten-free
February 21, 2019 - Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
February 21, 2019 - Anticipatory signals in eye movements can help measure attentive capacity, learning with greater precision
February 21, 2019 - Evening exercise does not negatively affect sleep, may also reduce hunger
February 21, 2019 - Artificial intelligence technique can be used to identify alcohol misuse in trauma setting
February 21, 2019 - Overweight, obesity in adolescence associated with increased risk of renal cancer later in life
February 21, 2019 - BGU develops new AI platform for monitoring and predicting ALS progression
February 21, 2019 - Researchers discover a new promising target to improve HIV vaccines
February 21, 2019 - Brief Anesthesia in Infancy Does Not Mar Neurodevelopment
February 21, 2019 - Gaming system helps with autism diagnosis
February 21, 2019 - Heart Disease: Six Things Women Should Know
February 21, 2019 - More States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids
February 21, 2019 - Researchers explore case studies focused on industries that kill more people than employed
February 21, 2019 - Only half of GP practice buildings are fit for purpose
February 21, 2019 - Intense exercise, fasting and hormones can enhance waste-protein removal, study shows
February 21, 2019 - Scientists can monitor brain activity to predict epileptic seizures few minutes in advance
February 21, 2019 - Study quantifies hepatic and intestinal mRNA expression of Ugt isoforms in rats
February 21, 2019 - ‘Apple-Shaped’ Body? ‘Pear-Shaped’? Your Genes May Tell
February 21, 2019 - Can we repair the brain? The promise of stem cell technologies for treating Parkinson’s disease
February 21, 2019 - Trump Plan To Beat HIV Hits Rough Road In Rural America
February 21, 2019 - PENTAX Medical introduces new electrosurgical and argon plasma coagulation platforms
February 21, 2019 - Trump plan to beat HIV hits rough road in rural America
February 21, 2019 - Eating blueberries every day could help decrease blood pressure
February 21, 2019 - ‘No Second Chances’ report calls for new measures to combat cardiovascular disease in Australia
February 21, 2019 - Mayo clinic researchers discuss local case studies of leprosy
February 21, 2019 - Scientists demonstrate key role of salt in allergic immune reactions
February 21, 2019 - Experts propose revising the criteria for diagnosis of Parkinson’s disease
February 21, 2019 - The med student and the machine
February 21, 2019 - Hey, Hey! Ho, Ho! Is Striking For School Nurses The Way To Go?
February 21, 2019 - Latest research encourages children to move out and learn through physical activity
February 21, 2019 - Proper oral hygiene and regular visits to dentist can promote heart health
February 21, 2019 - New, versatile technique for remote control of transplanted cells in Parkinson’s
February 21, 2019 - Why melanoma tumors in the brain may be worse?
February 21, 2019 - New project aims to improve lung disease care in Appalachia
February 21, 2019 - Drug increases melanin production in some people with albinism
February 21, 2019 - Over 1 in 3 adults miss the mark on protein, finds study
February 21, 2019 - CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis
February 21, 2019 - A correlation between obesity and income has only developed in the past 30 years
February 21, 2019 - Baby, then work: An effort to help resident-parents in emergency medicine
February 21, 2019 - Heavy cigarette smoking could damage vision, say researchers
February 21, 2019 - Some drug combinations may be more effective than others for schizophrenic patients
February 21, 2019 - Combination of common antibiotics can eliminate multi-drug resistant E. coli
February 21, 2019 - Number of calls to U.S. Poison Control regarding kratom exposure increased
February 21, 2019 - New computational tool searches for factors that cause specific diseases
February 21, 2019 - New method to assess effectiveness of psychotherapies for social anxiety disorder
February 21, 2019 - New technology measures hormones that influence reproductive health efficiently
February 21, 2019 - Bat influenza viruses could potentially attack the cells of humans and livestock
February 21, 2019 - Immunotherapeutic antibody therapy to kill cancer has now progressed to patient testing
February 21, 2019 - Johns Hopkins scientists find new compound that may prevent reperfusion injury
February 21, 2019 - Researchers develop new way to deliver treatment for cartilage regeneration
February 21, 2019 - Study sheds new light on left ventricular dysfunction in ischemic heart disease
February 21, 2019 - New technique could expedite cancer diagnosis, lead to better patient outcomes
February 21, 2019 - New map of infant brain may aid early diagnosis of autism
February 21, 2019 - Human consciousness depends on the brain’s ability to maintain dynamics of neural activity
February 21, 2019 - Harmony Biosciences Announces File Acceptance Of Its New Drug Application For Pitolisant
February 21, 2019 - Medications could fill treatment gap for adolescents with obesity
February 21, 2019 - New antibiotics are desperately needed: Machine learning could help | News Center
February 21, 2019 - Researchers develop new computer game for dementia carers
February 21, 2019 - University of Dundee partners with Takeda to develop new treatments for tau pathology
February 21, 2019 - Influenza vaccine may be less effective in elderly patients, finds study
February 21, 2019 - Researchers explain why T cells lose their protective ability in inflamed tissues
February 21, 2019 - New optimization method rapidly analyzes nanomedicines for cancer treatment
February 21, 2019 - Viruses in the intestinal tracts can lead to islet autoimmunity and Type 1 diabetes
February 21, 2019 - Link between dietary fatty acid intake and hypertension found to be influenced by diabetes status
February 21, 2019 - FDA Approves Esperoct (turoctocog alfa pegol, N8-GP) for Hemophilia A
February 21, 2019 - ‘Boy erased’—why conversion therapies and ex-gay ministries should be outlawed
February 21, 2019 - Titia de Lange to give annual McCormick Lecture on March 8 | News Center
February 21, 2019 - Study reveals how helper T cells support memory cells to function optimally
February 21, 2019 - Autistic children with co-occurring ADHD have greater adaptive behavior impairments
February 21, 2019 - Elevated levels of key cellular process implicated in intestinal inflammation and IBD
February 20, 2019 - Over Half of Hip Replacements Expected to Last 25 Years
February 20, 2019 - Microscopic eye movements affect how we see contrast
February 20, 2019 - Computer vs. patient: Fighting for residents’ attention | News Center
Brown researchers uncover new clues about ALS progression

Brown researchers uncover new clues about ALS progression

image_pdfDownload PDFimage_print

Brown University researchers have uncovered new clues about the progression of Amyotrophic Lateral Sclerosis (ALS), a surprisingly common disease that causes the death of motor neurons that control voluntary muscles such as those involved in walking, talking, chewing or breathing.

A team led by Anne Hart, a professor of neuroscience at Brown, discovered that two different kinds of motor neurons that die in patients may die in different ways — an important insight for understanding the disease and, eventually, finding a cure. Their work was published on Monday, Oct. 8, in the journal PLOS Genetics.

ALS is characterized by the degeneration of motor neurons in the spine that directly control muscle movement. But in some people with ALS, neurons in the brain that issue commands to these spinal motor neurons also die. It’s not clear why both types of neurons are affected in some people with ALS, but not others.

“Our results raise the possibility that the glutamatergic neurons in the brains of some ALS patients die in ways that are somehow different than how the spinal cord neurons die,” said Hart, a researcher at Brown’s Carney Institute for Brain Science. “Before, we all assumed that both kinds of neurons died the exact same way.”

And the implications could be significant, Hart said — this is the first clue that future treatments developed for spinal cord neurons might not cure all people with ALS, because they won’t help affected neurons in the brain.

Though many cases of ALS don’t have a clear genetic component, about 1 percent of people with ALS have mutations in SOD1, a protein involved in breaking down naturally occurring free radicals from oxidative stress. Hart’s research team precisely and selectively engineered C. elegans– transparent worms about as long as a pinhead — so that the worm’s SOD1 gene would contain a mutation such as those found in these people with ALS.

The results could explain why only spinal neurons are affected in some people, yet neurons in both the spine and the brain die in others.

More research needs to be done to see if the findings from worms will hold true in mammalian brains and lead to a better understanding of why neurons degenerate in people with ALS.

“We certainly can’t prove this in worms,” Hart said, “but it opens up a whole new way of looking at ALS.”

Specific neuron death

The work in Hart’s lab to develop a new ALS model has been a long-term effort. Seven years ago, postdoctoral researcher Jill Yersak began engineering different ALS mutations into worms. Worms have neurons very similar to human neurons and are less expensive and produce results faster than mice or other mammals, Hart said.

The project was completed by graduate student Saba Baskoylu. Then, the Brown research team ran numerous tests to see how the different patient versions of the SOD1 protein affected neuron function, motor neuron death and worm behavior.

Hart’s team found that four patient gene mutations caused neurodegeneration after oxidative stress in a type of neuron similar to those in the human spine, likely through increased toxic protein accumulation that doesn’t happen with the normal protein. However, two patient gene mutations also caused degeneration in a different type of neuron –similar to the neurons in the human brain–in part because the mutant protein no longer functioned correctly during oxidative stress.

The other kinds of neurons were healthy in the new ALS models, even after oxidative stress, which is very much like the specificity of neuron death in people with ALS, said Hart. In contrast, previous worm models weren’t very specific — almost any worm neuron could be killed by the patient version of SOD1.

Precise worm models

These earlier worm models were made by adding extra copies of a patient disease gene to the worms, which would then express the patient version of SOD1 at high levels. Now, thanks to new genetic tools like CRISPR/Cas9, directly editing the genes of worms and other animals is affordable and reliable. That allows scientists to make more precise models compared to simply adding extra copies of a gene, said Hart.

Hart’s goal was a more precise disease model that would let her group study the earliest events in ALS, by using these tools to change one “letter” in the worms’ standard “blueprint” for the SOD1 protein. The worms should have normal amounts of the protein and no extra gene copies.

The team accomplished their goal and discovered that the glutamatergic neurons –similar to the ALS-affected neurons in human brains — and the cholinergic neurons –similar to the spinal neurons — in worms degrade for different reasons. They will do more research on these worm models.

“We can now use these new ALS models to find other proteins and genes that we can use to stop neurodegeneration in worms,” Hart said. She plans to use the models to test many different small molecules for potential therapeutic drugs and to find other genes whose inactivation will suppress neurodegeneration. Then, collaborators, including those in other Brown labs, can test these genes in mice or human cell cultures, with the hope of helping people with ALS.

“ALS is complicated, you can see why it’s taking everyone a while to figure out what’s going on,” Hart said.

Source:

https://news.brown.edu/articles/2018/10/als

Tagged with:

About author

Related Articles